Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells

References

1. Anderson M. J. 1987; Parvoviruses as agents of human disease. Progress in Medical Virology 34:55–69
   [Google Scholar]
2. Anderson L. J., Tsou C., Parker R. A., Chorba T. L., Wulff H., Tattersall P., Mortimer P. P. 1986; Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 24:522526
   [Google Scholar]
3. Beard C., St Amand J., Astell C. R. 1989; Transient expression of B19 parvovirus gene products in COS-7 transfected with B19-SV40 hybrid vectors. Virology 172:659–664
   [Google Scholar]
4. Brown K. E., Cohen B. J. 1992; Haemagglutination by parvovirus B19. Journal of General Virology 73:2147–2149
   [Google Scholar]
5. Brown C. S., Van Bussel M. J., Wassenaar A. L., van Elsacker-Niele A. M., Weiland H. T., Salimans M. M. 1990; An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. Journal of Virological Methods 29:53–62
   [Google Scholar]
6. Brown C. S., Van Lent J. W., Vlak J. M., Spaan W. J. 1991; Assembly of capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. Journal of Virology 65:2702–2706
   [Google Scholar]
7. Brown C. S., Jenson T., Meloen R. H., Puijk W., Sugamura K., Sato H., Spaan W. J. M. 1992; Localization of an immunodominant domain on baculovirus-produced B19 capsids: correlation to a major surface region on the native virus particle. Journal of Virology 66:6989–6996
   [Google Scholar]
8. Brown K. E., Anderson S. M., Young N. S. 1993; Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117
   [Google Scholar]
9. Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Diagnostic assays with monoclonal antibodies for the human serum parvoviruslike virus (SPLV). Journal of Hygiene 91:113–130
   [Google Scholar]
10. Cohen B. J., Courouce A. M., Schwarz T. F., Okochi K., Kurtzman G. J. 1988; Laboratory infection with parvovirus B19 [letter]. Journal of Clinical Pathology 41:1027–1028
    [Google Scholar]
11. Cohen B. J., Field A. M., Gudnadottir S., Beard S., Barbara J. A. 1990; Blood donor screening for parvovirus B19. Journal of Virological Methods 30:233–238
    [Google Scholar]
12. Fridell E., Cohen B. J., Wahren B. 1991; Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19. Journal of Clinical Microbiology 29:1376–1381
    [Google Scholar]
13. Kajigaya S., Shimada T., Fujita S., Young N. S. 1989; A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proceedings of the National Academy of Sciences, USA 86:7601–7605
    [Google Scholar]
14. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfield S., Anderson L. J., Shimada T., Young N. S. 1991; Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proceedings of the National Academy of Sciences, USA 88:4646–4650
    [Google Scholar]
15. Koch W. C., Adler S. P. 1989; Human parvovirus B19 infections in women of childbearing age and within families. Pediatric Infectious Diseases Journal 8:83–87
    [Google Scholar]
16. Luo W., Astell C. R. 1993; A novel protein encoded by small RNAs of parvovirus B19. Virology 195:448–455
    [Google Scholar]
17. Mori J., Field A. M., Clewley J. P., Cohen B. J. 1989; Dot blot hybridisation assay of B19 virus DNA in clinical specimens. Journal of Clinical Microbiology 27:459–464
    [Google Scholar]
18. O’Neill H. J., Coyle P. V. 1992; Two anti-parvovirus B19 IgM capture assays incorporating a mouse monoclonal antibody specific for B19 viral capsid proteins VP1 and VP2. Archives of Virology 123:125–134
    [Google Scholar]
19. Rayment F. B., Crosdale E., Morris D. J., Pattison J. R., Talbot P., Clare J. J. 1990; The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. Journal of General Virology 71:2665–2672
    [Google Scholar]
20. Rosenfeld S. J., Young N. S., Alling D., Ayub J., Saxinger C. 1994; Subunit interaction in B19 empty capsids. Archives of Virology 136:9–18
    [Google Scholar]
21. Salimans M. M. M., van Bussel J. A. W. M., Brown C. S., Spaan W. J. M. 1992; Recombinant parvovirus B19 capsids as a new substrate for detection of B 19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay. Journal of Virological Methods 39:247–258
    [Google Scholar]
22. Sato H., Hirata J., Furukawa M., Kuroda N., Shiraki H., Maeda Y., Okochi K. 1991; Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. Journal of Virology 65:1667–1672
    [Google Scholar]
23. Sisk W. P., Berman M. L. 1987; Expression of human parvovirus B19 structural protein in E. coli and detection of anti-viral antibodies in human serum. Bio/Technology 5:1077–1080
    [Google Scholar]
24. St Amand & Astell C. R. 1993; Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology 192:121–131
    [Google Scholar]
25. Yoshimoto K., Rosenfeld S., Frickhofen N., Kennedy D., Hills R., Kajigaya S., Young N. S. 1991; A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. Journal of Virology 65:7056–7060
    [Google Scholar]